During the past decade, The National Brain Mapping Laboratory (NBML) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The National Brain Mapping Laboratory (NBML)" #1 collaborator was "Leibniz Research Centre for Working Environment and Human Factors" with 2 trials as a collaborator, "University of Tehran" with 2 trials as a collaborator, "Ardabil University of Medical Sciences" with 1 trials as a collaborator, "Ruhr University of Bochum" with 1 trials as a collaborator and "University of British Columbia" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The National Brain Mapping Laboratory (NBML)" are "Autism Spectrum Disorder" (1 trials), "Cognitive Impairment" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "The National Brain Mapping Laboratory (NBML)" in a lesser frequency.

Most popular intervention types in "The National Brain Mapping Laboratory (NBML)" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "transcranial direct current stimulation" (2 trials), "Placebo" (1 trials), "RisperiDONE 1 MG/ML" (1 trials) and "sham transcranial direct current stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "The National Brain Mapping Laboratory (NBML)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The National Brain Mapping Laboratory (NBML)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The National Brain Mapping Laboratory (NBML), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The National Brain Mapping Laboratory (NBML), 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".